<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02088567</url>
  </required_header>
  <id_info>
    <org_study_id>AFTKR001</org_study_id>
    <nct_id>NCT02088567</nct_id>
  </id_info>
  <brief_title>Amniotic Membrane in Total Knee Replacements to Reduce Scarring</brief_title>
  <official_title>A Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane (dHACM) in Total Knee Replacement Patients to Reduce Post-operative Scarring.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MiMedx Group, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MiMedx Group, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to evaluate the effectiveness of dHACM in reducing
      scar tissue formation in total knee replacement patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increased range of motion between both groups as measured by goniometer</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of need for manual manipulation of affected knee</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Increased Quality of Life as assessed by WOMAC and SF-36</measure>
    <time_frame>6 weeks</time_frame>
    <description>Western Ontario and McMaster Universities Arthritis Index (WOMAC) and Short Form 36 (SF-36) are measures of patient health status and quality of life.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Scarring</condition>
  <arm_group>
    <arm_group_label>dHACM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total knee arthroplasty, per the usual practice of the physician with application of dHACM between the underlying fascia and the overlying skin layers to reduce scar formation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Total knee arthroplasty, per the usual practice of the physician without application of dHACM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total Knee Arthroplasty</intervention_name>
    <description>Total knee arthroplasty, per the usual practice of the physician.</description>
    <arm_group_label>dHACM</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Application of dHACM</intervention_name>
    <description>Application of dHACM at end of procedure before closing wound between the underlying fascia and the overlying skin layers to reduce scar formation</description>
    <arm_group_label>dHACM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Are adults ages 18 or older.

          2. Are diagnosed with advanced osteoarthritis as determined by clinical exam and
             necessitate total knee replacement.

          3. Have a willingness to comply with follow-up examination.

          4. Have ability to give full written consent.

        Exclusion Criteria:

          1. Has had a previous total or partial joint replacement performed at the same site

          2. Has a planned bilateral procedure at this time. Bilateral patients can be enrolled if
             the procedures are staged.

          3. Has signs or symptoms of any other disease which could result in allograft failure, or
             has experienced allograft failure in the past.

          4. Has used any investigational drug(s) or therapeutic device(s) within 30 days preceding
             screening.

          5. Is pregnant or may become pregnant during the study.

          6. Is a prisoner.

          7. Has any condition(s) which seriously compromises the subject's ability to participate
             in this study, or has a known history of poor adherence with medical treatment.

          8. Is currently taking medications which could affect allograft incorporation
             (supervising physician's discretion).

          9. Is confined to bed or a wheelchair.

         10. Has clinical signs and symptoms of local infection at the site.

         11. Has autoimmune disease or a known history of having Acquired Immunodeficiency Syndrome
             (AIDS) or HIV.

         12. Has current diagnosis of cancer at the site.

         13. Has had prior radiation therapy treatment at the site.

         14. Is currently taking anticoagulant therapy.

         15. Is unable to sign or understand informed consent.

         16. Has a history of drug or alcohol abuse within last 12 months.

         17. Is allergic to Aminoglycoside antibiotics (such as gentamicin and/or streptomycin).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurice Jove, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgia Knee and Sports Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Georgia Knee and Sports Medicine</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2014</study_first_posted>
  <last_update_submitted>September 21, 2015</last_update_submitted>
  <last_update_submitted_qc>September 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

